Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023
08.03.2023 - BEDMINSTER, N.J., March 08, 2023 (GLOBE NEWSWIRE) - Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its ...
Source: wallstreet-online.de